Genetic susceptibility to a higher FCGR2A level was linked to a reduced risk of ulcerative colitis, whereas a genetically predicted higher PAM level was associated with an increased risk of chronic ulcerative colitis. This evidence concerns the gene FCGR2A and ulcerative colitis.